
Despite decriminalization efforts underway across the country, the DEA proposed putting five psychedelic compounds in the Schedule I category of the Controlled Substances Act.
The agency’s ban of 4-OH-DiPT, 5-MeO-AMT, 5-MeO-MiPT, 5-MeO-DET, and DiPT would put five tryptamines in the same category as drugs like heroin, ecstacy, LSD and of course cannabis.